![Bryan Giraudo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Giraudo
Directeur Financier/CFO chez
GOSSAMER BIO, INC.
Fortune : 4 M $ au 31/05/2026
Profil
Bryan Giraudo is currently an Independent Director at Valerio Therapeutics SA since 2021, an Independent Director at Protagonist Therapeutics, Inc. since 2018, and Chief Financial & Operating Officer at Gossamer Bio, Inc. since 2021.
Former positions include Senior Managing Director at Leerink Partners LLC from 2009 to 2018, Managing Director at Merrill Lynch & Co., Inc. from 1997 to 2009, and Managing Director at Pierce Fenner & Smith, Inc. Education includes an undergraduate degree from Georgetown University conferred in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/05/2026 | 40 520 ( 0,06 % ) | 4 M $ | 31/05/2026 | |
GOSSAMER BIO, INC. 0,12 % | 20/04/2026 | 572 747 ( 0,12 % ) | 132 305 $ | 31/05/2026 |
Postes actifs de Bryan Giraudo
| Sociétés | Poste | Début |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/05/2018 |
| GOSSAMER BIO, INC. | Directeur Financier/CFO | 07/05/2018 |
| VALERIO THERAPEUTICS | Directeur/Membre du Conseil | 23/11/2021 |
Anciens postes connus de Bryan Giraudo
| Sociétés | Poste | Fin |
|---|---|---|
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/05/2018 |
Merrill Lynch & Co., Inc.
 Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Corporate Officer/Principal | 01/07/2009 |
Pierce Fenner & Smith, Inc.
 Pierce Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides securities brokerage services | Corporate Officer/Principal | - |
Formation de Bryan Giraudo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
100
+
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pierce Fenner & Smith, Inc.
Pierce Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Merrill Lynch & Co., Inc.
Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
